 HAYWARD, Calif.--BUSINESS WIRE--Arcus Biosciences NYSE:RCUS, a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences: Citi 17th Annual BioPharma Conference Date: Wednesday, September 7th, 2022 Location: Boston, MA Format: 1-on-1 meetings only Morgan Stanley 20th Annual Global Healthcare Conference Date: 